Intensity Therapeutics, Inc. (INTS)
NASDAQ: INTS · Real-Time Price · USD
5.17
-0.06 (-1.15%)
At close: Apr 28, 2026, 4:00 PM EDT
5.35
+0.18 (3.48%)
After-hours: Apr 28, 2026, 5:21 PM EDT
Intensity Therapeutics Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Selling, General & Admin | 5.19 | 6.09 | 3.53 | 2.42 | 2.16 | |
| Research & Development | 6.79 | 10.5 | 4.79 | 5.13 | 5.86 | |
| Operating Expenses | 11.97 | 16.59 | 8.32 | 7.55 | 8.01 | |
| Operating Income | -11.97 | -16.59 | -8.32 | -7.55 | -8.01 | |
| Interest Expense | - | - | -0.31 | -0.08 | - | |
| Interest & Investment Income | 0.18 | 0.31 | 0.32 | 0 | 0 | |
| Other Non Operating Income (Expenses) | 0.19 | 0 | 0.02 | 0.05 | 0.12 | |
| EBT Excluding Unusual Items | -11.61 | -16.27 | -8.28 | -7.58 | -7.9 | |
| Other Unusual Items | - | - | -2.26 | - | - | |
| Pretax Income | -11.61 | -16.27 | -10.54 | -7.58 | -7.9 | |
| Net Income | -11.61 | -16.27 | -10.54 | -7.58 | -7.9 | |
| Preferred Dividends & Other Adjustments | - | - | 1.32 | - | - | |
| Net Income to Common | -11.61 | -16.27 | -11.86 | -7.58 | -7.9 | |
| Shares Outstanding (Basic) | 1 | 1 | 0 | 0 | 0 | |
| Shares Outstanding (Diluted) | 1 | 1 | 0 | 0 | 0 | |
| Shares Change (YoY) | 143.83% | 61.40% | 152.67% | - | 0.02% | |
| EPS (Basic) | -8.56 | -29.24 | -34.42 | -55.58 | -57.88 | |
| EPS (Diluted) | -8.56 | -29.24 | -34.42 | -55.58 | -57.88 | |
| EBIT | -11.97 | -16.59 | -8.32 | -7.55 | -8.01 | |
Source: S&P Capital IQ. Standard template.
Financial Sources.